Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Other Non-Current Assets (2020 - 2025)

Historic Other Non-Current Assets for Oncology Institute (TOI) over the last 6 years, with Q3 2025 value amounting to $586000.0.

  • Oncology Institute's Other Non-Current Assets fell 34.01% to $586000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $586000.0, marking a year-over-year decrease of 34.01%. This contributed to the annual value of $589000.0 for FY2024, which is 499.11% up from last year.
  • Per Oncology Institute's latest filing, its Other Non-Current Assets stood at $586000.0 for Q3 2025, which was down 34.01% from $586000.0 recorded in Q2 2025.
  • In the past 5 years, Oncology Institute's Other Non-Current Assets registered a high of $875000.0 during Q4 2021, and its lowest value of $407000.0 during Q2 2022.
  • Moreover, its 5-year median value for Other Non-Current Assets was $575000.0 (2024), whereas its average is $586875.0.
  • In the last 5 years, Oncology Institute's Other Non-Current Assets surged by 61721.31% in 2021 and then crashed by 4548.57% in 2022.
  • Over the past 5 years, Oncology Institute's Other Non-Current Assets (Quarter) stood at $875000.0 in 2021, then tumbled by 45.49% to $477000.0 in 2022, then increased by 17.61% to $561000.0 in 2023, then increased by 4.99% to $589000.0 in 2024, then fell by 0.51% to $586000.0 in 2025.
  • Its last three reported values are $586000.0 in Q3 2025, $586000.0 for Q2 2025, and $591000.0 during Q1 2025.